AKT1 and cancer: These data reveal that CTSG absence exhibits cancer stimulative impacts through Akt/mTOR signaling pathway activation and Akt signaling pathway suppression by MK2206 abolishes CTSG silenced expression-induced up-regulation of Bcl2 and cell viability in vitro and in vivo.